MBBS (Hons), FCICM, FRACP, PGDipEcho Claire is a senior intensive care specialist, and became Director of ICU in 2020. Originally from Tasmania, Claire completed her medical degree in Hobart in 1999. After training at both The Alfred and Barwon Health, Claire began work as a Specialist in Barwon Health ICU in 2009. Major clinical projects include developing the Paediatric ICU program in University Hospital Geelong. Her work in this area was a significant factor in UHG being awarded the Victorian Premier’s Health Care Secretary Award for Improving Patient Outcomes and Patient Experience in 2014. Claire has a strong interest in education, having involvement with Deakin University, and ICU Supervisor of Training. Claire is also involved in Quality and Safety activities and is current Chair of the Blood and Blood Products Committee.
Clinical leadership
Claire became Director of Intensive Care at University Hospital Geelong in 2020. She has undertaken the Harvard Emerging Women Executives in Health Care Program, and is Chair of the Barwon Health Blood and Blood Products Committee, and led the development of the Barwon Health Paediatric Critical Care Program from 2011-2018.
Latest news:
-
Tuesday, May 26, 2020 - 11:40
NEJM COVID Ethics - Crisis triage, how do we decide, not discriminate against disability, understand quality of life from the patient perspective, and apply prognostic estimates to a new disease?
Wednesday, May 20, 2020 - 21:48BMJ hydroxychloroquine treatment at 600 mg/day in hospitalised patients with with COVID-19 requiring O2 was not associated with decrease ICU admission or 21-day survival after hospital admission compared with standard care
Wednesday, May 20, 2020 - 20:32JC JAMA retrospective study of 1438 hospitalised patients with COVID-19 receiving hydroxychloroquine with or without azithromycin reported no significant difference in mortality
Wednesday, May 20, 2020 - 18:28JC NEJM Observational propensity matched study of hydroxychloroquine use in patients with COVID-19 and moderate-severe respiratory illness, reported no association of benefit or harm with relation to primary outcome or death or intubation
Tuesday, April 21, 2020 - 16:51